38089 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 23
17:31 UTC
|
PATH
UiPath
|
◎ Target | Terry Tillman ★★★★★ #219 | Hold | $17.00→ $14.00-17.6% |
|
Sep 23
17:31 UTC
|
MTB
M&T Bank
|
◎ Target | Brian Foran ★★★★☆ #667 | Hold | $268.00→ $250.00-6.7% |
|
Sep 23
17:31 UTC
|
HBAN
Huntington Bancshares
|
◎ Target | Brian Foran ★★★★☆ #667 | Buy | $20.00→ $19.00-5.0% |
|
Sep 23
17:31 UTC
|
FITB
Fifth Third Bancorp
|
◎ Target | Brian Foran ★★★★☆ #667 | Buy | $64.00→ $63.00-1.6% |
|
Sep 23
16:31 UTC
|
NOC
Northrop Grumman
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $653.00→ $620.00-5.1% |
|
Sep 23
16:31 UTC
|
MU
Micron Technology
|
◎ Target | Aaron Rakers ★★★★☆ #678 | Overweight | $1,525.00→ $1,400.00-8.2% |
|
Sep 23
16:31 UTC
|
LHX
L3Harris Technologies
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Outperform | $365.00→ $346.00-5.2% |
|
Sep 23
16:31 UTC
|
LGND
Ligand Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2792 | Buy | $390.00→ $397.00+1.8% |
|
Sep 23
16:31 UTC
|
KEY
KeyCorp
|
◎ Target | Brian Foran ★★★★☆ #667 | Hold | $24.00→ $23.00-4.2% |
|
Sep 23
16:31 UTC
|
KBH
KB Home
|
◎ Target | Jonathan Bettenhausen ★★★☆☆ #1656 | Hold | $55.00→ $50.00-9.1% |
|
Sep 23
16:31 UTC
|
GS
The Goldman Sachs Group
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $1,200.00→ $1,050.00-12.5% |
|
Sep 23
16:31 UTC
|
GD
General Dynamics
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $421.00→ $407.00-3.3% |
|
Sep 23
16:31 UTC
|
EQT
EQT
|
◎ Target | Scott Gruber ★★★☆☆ #1203 | Buy | $67.00→ $68.00+1.5% |
|
Sep 23
16:31 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Brian Foran ★★★★☆ #667 | Hold | $80.00→ $77.00-3.8% |
|
Sep 23
16:31 UTC
|
AZO
AutoZone
|
◎ Target | Scot Ciccarelli ★★★★☆ #968 | Buy | $3,817.00→ $3,648.00-4.4% |
|
Sep 23
16:31 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Srikripa Devarakonda ★★★★☆ #465 | Buy | $200.00→ $285.00+42.5% |
|
Sep 23
16:31 UTC
|
AXP
American Express
|
◎ Target | Brian Foran ★★★★☆ #667 | Buy | $375.00→ $370.00-1.3% |
|
Sep 23
16:31 UTC
|
ALLY
Ally Financial
|
◎ Target | Brian Foran ★★★★☆ #667 | Buy | $51.00→ $50.00-2.0% |
|
Sep 23
15:31 UTC
|
PM
Philip Morris International
|
◎ Target | Faham Baig ★★★☆☆ #1011 | Neutral | $182.00→ $192.00+5.5% |
|
Sep 23
15:31 UTC
|
MU
Micron Technology
|
◎ Target | Atif Malik ★★★☆☆ #1526 | Buy | $1,150.00→ $1,300.00+13.0% |
|
Sep 23
15:31 UTC
|
HII
Huntington Ingalls Industries
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $341.00→ $327.00-4.1% |
|
Sep 23
15:31 UTC
|
BSVN
Bank7
|
◎ Target | Woody Lay not yet tracked | Outperform | $56.00→ $62.00+10.7% |
|
Sep 23
15:31 UTC
|
AZO
AutoZone
|
◎ Target | Max Rakhlenko ★★★☆☆ #1035 | Buy | $3,500.00→ $3,400.00-2.9% |
|
Sep 23
14:14 UTC
|
WFRD
Weatherford International
|
◎ Target | Josh Silverstein ★★★☆☆ #1222 | Buy | $120.00→ $116.00-3.3% |
|
Sep 23
14:14 UTC
|
STZ
Constellation Brands
|
◎ Target | Peter Grom ★★★★☆ #401 | Buy | $168.00→ $145.00-13.7% |
|
Sep 23
14:14 UTC
|
PATH
UiPath
|
◎ Target | Radi Sultan ★★★★★ #96 | Neutral | $19.00→ $15.00-21.1% |
|
Sep 23
14:14 UTC
|
PATH
UiPath
|
◎ Target | Matthew Hedberg ★★★★★ #162 | Sec→ r Perform | $17.00→ $15.00-11.8% |
|
Sep 23
14:14 UTC
|
KNX
Knight-Swift Transportation
|
◎ Target | Ken Hoexter ★★★☆☆ #1467 | Buy | $98.00→ $92.00-6.1% |
|
Sep 23
14:14 UTC
|
KMX
CarMax
|
◎ Target | Daniela Haigian ★★★☆☆ #1171 | Cautious | $44.00→ $47.00+6.8% |
|
Sep 23
14:14 UTC
|
KBH
KB Home
|
◎ Target | Mike Dahl not yet tracked | Sec→ r Perform | $53.00→ $50.00-5.7% |
|
Sep 23
14:14 UTC
|
FSLY
Fastly
|
◎ Target | Rudy Kessinger ★★★★★ #58 | Neutral | $21.00→ $23.00+9.5% |
|
Sep 23
14:14 UTC
|
FSLY
Fastly
|
◎ Target | Tal Liani ★★★★★ #291 | Underperform | $20.00→ $22.00+10.0% |
|
Sep 23
14:14 UTC
|
CNI
Canadian National Railway
|
◎ Target | Ken Hoexter ★★★☆☆ #1467 | Buy | $146.00→ $143.00-2.1% |
|
Sep 23
14:14 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Thomas Smith ★★☆☆☆ #2812 | Outperform | $70.00→ $88.00+25.7% |
|
Sep 23
14:14 UTC
|
AZO
AutoZone
|
◎ Target | Michael Baker ★★★★☆ #587 | Buy | $3,750.00→ $3,500.00-6.7% |
|
Sep 23
14:14 UTC
|
ANAB
AnaptysBio
|
◎ Target | David Risinger ★★★★☆ #917 | Outperform | $90.00→ $81.00-10.0% |
|
Sep 23
14:14 UTC
|
ACHC
Acadia Healthcare
|
◎ Target | Whit Mayo ★★★☆☆ #1154 | Market Perform | $30.00→ $33.00+10.0% |
|
Sep 23
13:14 UTC
|
THO
Thor Industries
|
◎ Target | Craig Kennison ★★☆☆☆ #2814 | Neutral | $90.00→ $80.00-11.1% |
|
Sep 23
13:14 UTC
|
SW
Smurfit Westrock
|
◎ Target | Detlef Winckelmann ★★★☆☆ #1005 | Overweight | $68.00→ $69.00+1.5% |
|
Sep 23
13:14 UTC
|
RBRK
Rubrik
|
◎ Target | Shrenik Kothari ★★★★★ #14 | Outperform | $130.00→ $139.00+6.9% |
|
Sep 23
13:14 UTC
|
PM
Philip Morris International
|
◎ Target | Faham Baig ★★★☆☆ #1011 | Neutral | $182.00→ $193.00+6.0% |
|
Sep 23
13:14 UTC
|
PKG
Packaging Corporation of America
|
◎ Target | Detlef Winckelmann ★★★☆☆ #1005 | Overweight | $312.00→ $320.00+2.6% |
|
Sep 23
13:14 UTC
|
PBR
Petroleo Brasileiro S.A.- Petrobras
|
◎ Target | Matheus Enfeldt not yet tracked | Buy | $22.00→ $23.00+4.5% |
|
Sep 23
13:14 UTC
|
ONON
ON
|
◎ Target | Tom Nikic ★★★★☆ #801 | Buy | $37.00→ $40.00+8.1% |
|
Sep 23
13:14 UTC
|
NKTR
Nektar Therapeutics
|
◎ Target | Martin Fan ★★★☆☆ #1776 | Neutral | $80.00→ $50.00-37.5% |
|
Sep 23
13:14 UTC
|
KBH
KB Home
|
◎ Target | Matthew Bouley ★★★☆☆ #1302 | Overweight | $57.00→ $49.00-14.0% |
|
Sep 23
13:14 UTC
|
KBH
KB Home
|
◎ Target | James McCanless not yet tracked | Market Outperform | $77.00→ $70.00-9.1% |
|
Sep 23
13:14 UTC
|
IP
International Paper
|
◎ Target | Detlef Winckelmann ★★★☆☆ #1005 | Overweight | $61.00→ $62.00+1.6% |
|
Sep 23
13:14 UTC
|
DPZ
Domino's Pizza
|
◎ Target | Gregory Francfort ★★☆☆☆ #2536 | Neutral | $440.00→ $325.00-26.1% |
|
Sep 23
13:14 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Michael Schmidt ★★☆☆☆ #2413 | Buy | $4.00 |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.